Keyphrases
Randomized Placebo-controlled Trial
100%
Divalproex Sodium
100%
Acute Exacerbation
100%
Divalproex
100%
Chronic Schizophrenia
100%
Haloperidol
50%
Placebo
33%
Carry-over Effects
33%
Hospitalized Patients
16%
Clinical Setting
16%
Schizophrenia Treatment
16%
Negative Symptoms
16%
Clinical Data
16%
Serum Concentration
16%
Symptom Score
16%
Small Sample Size
16%
Clinical Global Impression Scale
16%
Antipsychotics
16%
Placebo Groups
16%
Valproate
16%
Brief Psychiatric Rating Scale
16%
Augmentation Strategy
16%
Psychiatric Rating Scales
16%
GABAergic Drugs
16%
Add-on Treatment
16%
Acute Schizophrenia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Schizophrenia
100%
Valproate Semisodium
100%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
33%
Disease
11%
Prematurity
11%
4 Aminobutyric Acid
11%
Negative Syndrome
11%
Isoprenaline
11%
Sodium Valproate
11%
Antipsychotic
11%
Typical Antipsychotic
11%
Neuroscience
Placebo
100%
Schizophrenia
100%
Haloperidol
60%
Gamma-Aminobutyric Acid
20%
Negative Syndrome
20%
Typical Antipsychotic
20%
Isoprenaline
20%
Treatment of Schizophrenia
20%